Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	tissue morphogenesis	MYF5 UBE4B KAT2A DICER1 RYR2 FAT1 C2CD3 TP63 JAG1 LRP6 FGFR1 CSMD1 MAP3K7 EPHA7 SOS1	5.94e-06	750	105	15	GO:0048729
GeneOntologyBiologicalProcess	embryo development	MYF5 TENT5C MECOM KAT2A HORMAD1 DICER1 RYR2 HOXA7 BPTF C2CD3 ST8SIA6 BRCA2 TP63 JAG1 EHMT1 LRP6 PITPNB FGFR1 MAP3K7 SOS1 SPIC	9.73e-06	1437	105	21	GO:0009790
GeneOntologyBiologicalProcess	chordate embryonic development	MYF5 TENT5C MECOM KAT2A HORMAD1 DICER1 HOXA7 BPTF C2CD3 ST8SIA6 BRCA2 LRP6 PITPNB FGFR1 MAP3K7 SPIC	1.35e-05	906	105	16	GO:0043009
GeneOntologyBiologicalProcess	morphogenesis of an epithelium	KAT2A DICER1 RYR2 FAT1 C2CD3 TP63 JAG1 LRP6 FGFR1 CSMD1 MAP3K7 EPHA7 SOS1	1.57e-05	619	105	13	GO:0002009
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	MYF5 TENT5C MECOM KAT2A HORMAD1 DICER1 HOXA7 BPTF C2CD3 ST8SIA6 BRCA2 LRP6 PITPNB FGFR1 MAP3K7 SPIC	1.83e-05	929	105	16	GO:0009792
GeneOntologyBiologicalProcess	embryonic hindlimb morphogenesis	MECOM DICER1 TP63 LRP6	2.94e-05	35	105	4	GO:0035116
GeneOntologyBiologicalProcess	cell-cell adhesion	PCDHGA6 VSIG4 VSIR HAVCR2 CEACAM19 NLGN3 SLFN12L FAT1 HMCN2 CELSR3 VNN1 JAG1 LRP6 NLGN2 CTNND2 SDK1 EPHA7	2.98e-05	1077	105	17	GO:0098609
GeneOntologyBiologicalProcess	epithelium development	MYF5 KRT15 KRT34 MECOM KAT2A DICER1 RYR2 HOXA7 FAT1 C2CD3 BRCA2 TP63 JAG1 LRP6 FGFR1 CSMD1 MAP3K7 HYDIN EPHA7 SOS1	4.52e-05	1469	105	20	GO:0060429
GeneOntologyBiologicalProcess	in utero embryonic development	TENT5C MECOM KAT2A HORMAD1 DICER1 BPTF C2CD3 ST8SIA6 BRCA2 PITPNB FGFR1 SPIC	5.13e-05	596	105	12	GO:0001701
GeneOntologyBiologicalProcess	embryonic limb morphogenesis	MECOM DICER1 C2CD3 TP63 LRP6 FGFR1	1.11e-04	148	105	6	GO:0030326
GeneOntologyBiologicalProcess	embryonic appendage morphogenesis	MECOM DICER1 C2CD3 TP63 LRP6 FGFR1	1.11e-04	148	105	6	GO:0035113
GeneOntologyBiologicalProcess	hindlimb morphogenesis	MECOM DICER1 TP63 LRP6	1.13e-04	49	105	4	GO:0035137
GeneOntologyBiologicalProcess	negative regulation of type II interferon production	VSIR HAVCR2 CD96 NR1H4	1.32e-04	51	105	4	GO:0032689
GeneOntologyBiologicalProcess	limb development	MECOM KAT2A DICER1 C2CD3 TP63 LRP6 FGFR1	1.50e-04	224	105	7	GO:0060173
GeneOntologyBiologicalProcess	appendage development	MECOM KAT2A DICER1 C2CD3 TP63 LRP6 FGFR1	1.50e-04	224	105	7	GO:0048736
GeneOntologyBiologicalProcess	cellular response to bile acid	KCNMB1 NR1H4	1.53e-04	4	105	2	GO:1903413
GeneOntologyBiologicalProcess	positive regulation of hepatic stellate cell proliferation	DDR2 DICER1	1.53e-04	4	105	2	GO:1904899
GeneOntologyBiologicalProcess	regulation of cell cycle	EPM2A ING3 PARP3 DDR2 MECOM KAT2A RRM1 HORMAD1 DICER1 SLFN12L BRCA2 TP63 LRP6 ZFYVE26 FGFR1 MAP3K7 DYNC1H1	1.96e-04	1256	105	17	GO:0051726
GeneOntologyBiologicalProcess	heart morphogenesis	UBE4B DICER1 RYR1 RYR2 C2CD3 JAG1 LRP6 SOS1	2.38e-04	321	105	8	GO:0003007
GeneOntologyBiologicalProcess	embryonic morphogenesis	MYF5 MECOM KAT2A DICER1 RYR2 HOXA7 C2CD3 TP63 LRP6 FGFR1 MAP3K7 SOS1	2.74e-04	713	105	12	GO:0048598
GeneOntologyBiologicalProcess	skeletal system development	MYF5 DDR2 KAT2A DICER1 RYR1 HOXA7 LOX TP63 LRP6 FGFR1 MAP3K7	2.99e-04	615	105	11	GO:0001501
GeneOntologyBiologicalProcess	morphogenesis of a branching structure	DICER1 TP63 LRP6 FGFR1 CTNND2 CSMD1 EPHA7	3.55e-04	258	105	7	GO:0001763
GeneOntologyBiologicalProcess	appendage morphogenesis	MECOM DICER1 C2CD3 TP63 LRP6 FGFR1	3.70e-04	185	105	6	GO:0035107
GeneOntologyBiologicalProcess	limb morphogenesis	MECOM DICER1 C2CD3 TP63 LRP6 FGFR1	3.70e-04	185	105	6	GO:0035108
GeneOntologyBiologicalProcess	hepatic stellate cell proliferation	DDR2 DICER1	3.80e-04	6	105	2	GO:1990922
GeneOntologyBiologicalProcess	regulation of hepatic stellate cell proliferation	DDR2 DICER1	3.80e-04	6	105	2	GO:1904897
GeneOntologyBiologicalProcess	pericardium development	MECOM LRP6 SOS1	3.83e-04	28	105	3	GO:0060039
GeneOntologyBiologicalProcess	brain development	MECOM KAT2A RRM1 DICER1 BPTF C2CD3 BRCA2 LRP6 FGFR1 HYDIN SEZ6L EPHA7 SOS1	4.20e-04	859	105	13	GO:0007420
GeneOntologyBiologicalProcess	heart development	UBE4B MECOM KAT2A DICER1 RYR1 RYR2 C2CD3 LOX JAG1 LRP6 FGFR1 SOS1	4.70e-04	757	105	12	GO:0007507
GeneOntologyBiologicalProcess	negative regulation of interleukin-2 production	VSIG4 HAVCR2 NR1H4	5.19e-04	31	105	3	GO:0032703
GeneOntologyBiologicalProcess	response to bile acid	KCNMB1 NR1H4	5.30e-04	7	105	2	GO:1903412
GeneOntologyBiologicalProcess	forebrain neuroblast division	LRP6 FGFR1	5.30e-04	7	105	2	GO:0021873
GeneOntologyBiologicalProcess	regulation of interleukin-2 production	VSIG4 HAVCR2 MAP3K7 NR1H4	5.55e-04	74	105	4	GO:0032663
GeneOntologyBiologicalProcess	ossification	MYF5 TENT5A DDR2 RYR1 LOX TP63 JAG1 LRP6 FGFR1 MAP3K7	5.91e-04	562	105	10	GO:0001503
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN3 NLGN2	1.52e-04	4	106	2	GO:0098983
MousePheno	abnormal cranium size	TENT5A DDR2 LRP6 FGFR1 HYDIN SOS1	4.75e-05	97	94	6	MP:0010031
MousePheno	abnormal vertebral column morphology	MYF5 TENT5A GNPTAB TENT5C MECOM KAT2A HELQ RYR1 BPTF LOX TP63 LRP6 ZFYVE26 FGFR1 DCBLD2 HYDIN	6.46e-05	787	94	16	MP:0004703
MousePheno	abnormal joint morphology	HGD MYF5 TENT5A TENT5C MECOM BPTF TP63 EHMT1 LRP6 FGFR1 HYDIN	7.03e-05	397	94	11	MP:0002932
MousePheno	impaired somite development	MECOM KAT2A REV3L EHMT1 LRP6 FGFR1	7.03e-05	104	94	6	MP:0009768
MousePheno	small cranium	TENT5A DDR2 LRP6 FGFR1	7.62e-05	34	94	4	MP:0005352
Domain	CUB	TMPRSS15 CSMD3 CSMD1 DCBLD2 SEZ6L	7.27e-06	49	103	5	PF00431
Domain	CUB	TMPRSS15 CSMD3 CSMD1 DCBLD2 SEZ6L	8.05e-06	50	103	5	SM00042
Domain	-	TMPRSS15 CSMD3 CSMD1 DCBLD2 SEZ6L	9.79e-06	52	103	5	2.60.120.290
Domain	CUB	TMPRSS15 CSMD3 CSMD1 DCBLD2 SEZ6L	1.08e-05	53	103	5	PS01180
Domain	CUB_dom	TMPRSS15 CSMD3 CSMD1 DCBLD2 SEZ6L	1.54e-05	57	103	5	IPR000859
Domain	Carboxylesterase_B_CS	TG NLGN3 NLGN2	4.48e-05	13	103	3	IPR019819
Domain	CARBOXYLESTERASE_B_2	TG NLGN3 NLGN2	5.67e-05	14	103	3	PS00941
Domain	COesterase	TG NLGN3 NLGN2	5.67e-05	14	103	3	PF00135
Domain	CarbesteraseB	TG NLGN3 NLGN2	5.67e-05	14	103	3	IPR002018
Domain	V-set	VSIG2 BTNL8 VSIG4 VSIR HAVCR2 CEACAM19 CD96	7.18e-05	184	103	7	PF07686
Domain	Ryanodine_rcpt	RYR1 RYR2	9.00e-05	3	103	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR1 RYR2	9.00e-05	3	103	2	IPR009460
Domain	RyR	RYR1 RYR2	9.00e-05	3	103	2	PF02026
Domain	RR_TM4-6	RYR1 RYR2	9.00e-05	3	103	2	PF06459
Domain	Ryan_recept	RYR1 RYR2	9.00e-05	3	103	2	IPR013333
Domain	Ig_V-set	VSIG2 BTNL8 VSIG4 VSIR HAVCR2 CEACAM19 CD96	1.17e-04	199	103	7	IPR013106
Domain	DUF1693	TENT5A TENT5C	1.79e-04	4	103	2	IPR012937
Domain	DUF1693	TENT5A TENT5C	1.79e-04	4	103	2	SM01153
Domain	NTP_transf_7	TENT5A TENT5C	1.79e-04	4	103	2	PF07984
Domain	Sushi	CFHR1 CSMD3 CSMD1 SEZ6L	1.93e-04	52	103	4	PF00084
Domain	CCP	CFHR1 CSMD3 CSMD1 SEZ6L	2.23e-04	54	103	4	SM00032
Domain	SUSHI	CFHR1 CSMD3 CSMD1 SEZ6L	2.57e-04	56	103	4	PS50923
Domain	Sushi_SCR_CCP_dom	CFHR1 CSMD3 CSMD1 SEZ6L	2.75e-04	57	103	4	IPR000436
Domain	Nlgn	NLGN3 NLGN2	2.98e-04	5	103	2	IPR000460
Domain	RIH_assoc-dom	RYR1 RYR2	4.45e-04	6	103	2	IPR013662
Domain	Ins145_P3_rec	RYR1 RYR2	4.45e-04	6	103	2	PF08709
Domain	RIH_assoc	RYR1 RYR2	4.45e-04	6	103	2	PF08454
Domain	RIH_dom	RYR1 RYR2	4.45e-04	6	103	2	IPR000699
Domain	Ins145_P3_rcpt	RYR1 RYR2	4.45e-04	6	103	2	IPR014821
Domain	Ryanodine_recept-rel	RYR1 RYR2	4.45e-04	6	103	2	IPR015925
Domain	-	RYR1 RYR2	4.45e-04	6	103	2	1.25.10.30
Domain	RYDR_ITPR	RYR1 RYR2	4.45e-04	6	103	2	PF01365
Domain	Ig-like_dom	VSIG2 BTNL8 VSIG4 VSIR HAVCR2 CEACAM19 HMCN2 FGFR1 SDK1 CD96	4.61e-04	503	103	10	IPR007110
Domain	Ig-like_fold	EPM2A VSIG2 BTNL8 VSIG4 VSIR HAVCR2 CEACAM19 HMCN2 FGFR1 SDK1 CD96 EPHA7	5.10e-04	706	103	12	IPR013783
Domain	IG	VSIG2 BTNL8 VSIG4 VSIR HAVCR2 HMCN2 FGFR1 SDK1 CD96	5.34e-04	421	103	9	SM00409
Domain	Ig_sub	VSIG2 BTNL8 VSIG4 VSIR HAVCR2 HMCN2 FGFR1 SDK1 CD96	5.34e-04	421	103	9	IPR003599
Domain	-	EPM2A VSIG2 BTNL8 VSIG4 VSIR HAVCR2 CEACAM19 FGFR1 SDK1 CD96 EPHA7	1.07e-03	663	103	11	2.60.40.10
Domain	MIR	RYR1 RYR2	1.32e-03	10	103	2	PF02815
Domain	MIR_motif	RYR1 RYR2	1.32e-03	10	103	2	IPR016093
Domain	MIR	RYR1 RYR2	1.32e-03	10	103	2	PS50919
Domain	MIR	RYR1 RYR2	1.32e-03	10	103	2	SM00472
Domain	ConA-like_dom	TMPRSS15 BTNL8 RYR1 RYR2 FAT1 CELSR3	1.35e-03	219	103	6	IPR013320
Domain	IG_LIKE	VSIG2 BTNL8 VSIG4 VSIR HAVCR2 HMCN2 FGFR1 SDK1 CD96	1.57e-03	491	103	9	PS50835
Domain	Ephrin_rec_like	TG EPHA7	1.60e-03	11	103	2	PF07699
Domain	ASX_HYDROXYL	FAT1 HMCN2 CELSR3 JAG1	2.28e-03	100	103	4	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT1 HMCN2 CELSR3 JAG1	2.82e-03	106	103	4	IPR000152
Domain	-	SECISBP2L MRM3	3.02e-03	15	103	2	3.30.1330.30
Domain	L30e-like	SECISBP2L MRM3	3.02e-03	15	103	2	IPR029064
Domain	EGF-like_CS	FAT1 HMCN2 CELSR3 JAG1 LRP6 EPHA7	3.25e-03	261	103	6	IPR013032
Domain	EGF_2	FAT1 HMCN2 CELSR3 JAG1 LRP6 EPHA7	3.50e-03	265	103	6	PS01186
Domain	Ig_I-set	VSIG2 VSIG4 HMCN2 FGFR1 SDK1	4.05e-03	190	103	5	IPR013098
Domain	I-set	VSIG2 VSIG4 HMCN2 FGFR1 SDK1	4.05e-03	190	103	5	PF07679
Domain	EGF_CA	FAT1 HMCN2 CELSR3 JAG1	4.66e-03	122	103	4	SM00179
Domain	EGF-like_Ca-bd_dom	FAT1 HMCN2 CELSR3 JAG1	4.93e-03	124	103	4	IPR001881
Domain	EGF	FAT1 CELSR3 JAG1 LRP6	5.22e-03	126	103	4	PF00008
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DOCK3 UBE4B POLR2A MTMR8 KAT2A REV3L RYR1 FAT1 C2CD3 CELSR3 EHMT1 ZFYVE26 NLGN2 FGFR1 DYNC1H1 WNK2	2.45e-07	1105	106	16	35748872
Pubmed	Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.	BRCA2 JAG1 FGFR1	1.52e-06	8	106	3	18563556
Pubmed	The AERO system: a 3D-like approach for recording gene expression patterns in the whole mouse embryo.	MYF5 ING3 PEG3 HOXA7 TP63 NR1H4 SPIC	2.08e-06	191	106	7	24146773
Pubmed	Prdm16 is required for the maintenance of brown adipocyte identity and function in adult mice.	MYF5 MECOM RYR1 EHMT1	6.18e-06	39	106	4	24703692
Pubmed	The structure and expression of the human neuroligin-3 gene.	NLGN3 NLGN2	9.20e-06	2	106	2	10767552
Pubmed	Distinct roles for extracellular and intracellular domains in neuroligin function at inhibitory synapses.	NLGN3 NLGN2	9.20e-06	2	106	2	27805570
Pubmed	Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.	RYR1 RYR2	9.20e-06	2	106	2	17259277
Pubmed	Ryanodine receptor oligomeric interaction: identification of a putative binding region.	RYR1 RYR2	9.20e-06	2	106	2	14722100
Pubmed	Structural and functional interactions within ryanodine receptor.	RYR1 RYR2	9.20e-06	2	106	2	26009179
Pubmed	Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies-Present State, Challenges, and Perspectives.	RYR1 RYR2	9.20e-06	2	106	2	32899693
Pubmed	TENT5 cytoplasmic noncanonical poly(A) polymerases regulate the innate immune response in animals.	TENT5A TENT5C	9.20e-06	2	106	2	36383655
Pubmed	Expression and structural analysis of human neuroligin 2 and neuroligin 3 implicated in autism spectrum disorders.	NLGN3 NLGN2	9.20e-06	2	106	2	36479216
Pubmed	Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion.	RYR1 RYR2	9.20e-06	2	106	2	15033925
Pubmed	The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation.	UBE2I TP63	9.20e-06	2	106	2	15611636
Pubmed	Sumoylation regulates functional properties of the oocyte transcription factors SOHLH1 and NOBOX.	UBE2I NOBOX	9.20e-06	2	106	2	36607631
Pubmed	BRCA2 Regulates Transcription Elongation by RNA Polymerase II to Prevent R-Loop Accumulation.	POLR2A BRCA2	9.20e-06	2	106	2	29386125
Pubmed	U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha.	UBE4B TP63	9.20e-06	2	106	2	18418053
Pubmed	Recent advances in understanding the ryanodine receptor calcium release channels and their role in calcium signalling.	RYR1 RYR2	9.20e-06	2	106	2	30542613
Pubmed	Ryanodine receptors are expressed and functionally active in mouse spermatogenic cells and their inhibition interferes with spermatogonial differentiation.	RYR1 RYR2	9.20e-06	2	106	2	15280431
Pubmed	Expression of the ryanodine receptor isoforms in immune cells.	RYR1 RYR2	9.20e-06	2	106	2	11673493
Pubmed	B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.	RYR1 RYR2	9.20e-06	2	106	2	11673462
Pubmed	Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.	RYR1 RYR2	9.20e-06	2	106	2	25370123
Pubmed	Cytoplasmic polyadenylation by TENT5A is required for proper bone formation.	TENT5A TENT5C	9.20e-06	2	106	2	33882302
Pubmed	Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels.	RYR1 RYR2	9.20e-06	2	106	2	18618700
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR1 RYR2	2.76e-05	3	106	2	18403125
Pubmed	Identification of two new members of the CSMD gene family.	CSMD3 CSMD1	2.76e-05	3	106	2	12906867
Pubmed	Unique versus Redundant Functions of Neuroligin Genes in Shaping Excitatory and Inhibitory Synapse Properties.	NLGN3 NLGN2	2.76e-05	3	106	2	28607166
Pubmed	Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.	FGFR1 SOS1	2.76e-05	3	106	2	9480847
Pubmed	Developmental signals control chromosome segregation fidelity during pluripotency and neurogenesis by modulating replicative stress.	LRP6 FGFR1	2.76e-05	3	106	2	39191776
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR1 RYR2	2.76e-05	3	106	2	7876312
Pubmed	TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.	DICER1 TP63	2.76e-05	3	106	2	20962848
Pubmed	Dendritic differentiation of cerebellar Purkinje cells is promoted by ryanodine receptors expressed by Purkinje and granule cells.	RYR1 RYR2	2.76e-05	3	106	2	24123915
Pubmed	Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy.	CFHR1 MS4A1	2.76e-05	3	106	2	27528699
Pubmed	Differential Role of the RasGEFs Sos1 and Sos2 in Mouse Skin Homeostasis and Carcinogenesis.	POLR2A SOS1	2.76e-05	3	106	2	29844066
Pubmed	Dopamine D1 receptor signaling system regulates ryanodine receptor expression in ethanol physical dependence.	RYR1 RYR2	2.76e-05	3	106	2	23278119
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR1 RYR2	2.76e-05	3	106	2	22948152
Pubmed	Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits.	NLGN3 NLGN2	2.76e-05	3	106	2	29100073
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR1 RYR2	2.76e-05	3	106	2	10788707
Pubmed	SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide.	MECOM UBE2I	2.76e-05	3	106	2	23770046
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR1 RYR2	2.76e-05	3	106	2	7621815
Pubmed	Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity.	VSIR HAVCR2	2.76e-05	3	106	2	32117584
Pubmed	Altered sumoylation of p63alpha contributes to the split-hand/foot malformation phenotype.	UBE2I TP63	2.76e-05	3	106	2	15539951
Pubmed	Neuroligins Sculpt Cerebellar Purkinje-Cell Circuits by Differential Control of Distinct Classes of Synapses.	NLGN3 NLGN2	2.76e-05	3	106	2	26291161
Pubmed	Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses.	NLGN3 NLGN2	2.76e-05	3	106	2	17897391
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR1 RYR2	2.76e-05	3	106	2	10473538
Pubmed	Neuroligins determine synapse maturation and function.	NLGN3 NLGN2	2.76e-05	3	106	2	16982420
Pubmed	LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma-Potential Biomarkers for Targeted Therapy Concepts.	VSIR HAVCR2	2.76e-05	3	106	2	33396515
Pubmed	A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases.	VSIR HAVCR2	2.76e-05	3	106	2	36968142
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR1 RYR2	2.76e-05	3	106	2	18434746
Pubmed	Angiogenesis potential of human limbal stromal niche cells.	KRT15 TP63	2.76e-05	3	106	2	22538425
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR1 RYR2	2.76e-05	3	106	2	9204703
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR1 RYR2	2.76e-05	3	106	2	21881589
Pubmed	Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival.	POLR2A SOS1	2.76e-05	3	106	2	24043312
Pubmed	Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism.	NLGN3 NLGN2	2.76e-05	3	106	2	27217145
Pubmed	Human nuclear Dicer restricts the deleterious accumulation of endogenous double-stranded RNA.	POLR2A DICER1	2.76e-05	3	106	2	24814348
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR1 RYR2	2.76e-05	3	106	2	12213830
Pubmed	Destabilization of DeltaNp63alpha by Nedd4-mediated ubiquitination and Ubc9-mediated sumoylation, and its implications on dorsoventral patterning of the zebrafish embryo.	UBE2I TP63	2.76e-05	3	106	2	15908775
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR1 RYR2	2.76e-05	3	106	2	9242641
Pubmed	Direct association of the reticulon protein RTN1A with the ryanodine receptor 2 in neurons.	RYR1 RYR2	2.76e-05	3	106	2	23454728
Pubmed	BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers.	TP63 JAG1	2.76e-05	3	106	2	23863842
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR1 RYR2	2.76e-05	3	106	2	25239916
Pubmed	Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype.	DICER1 TP63	2.76e-05	3	106	2	24220032
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR1 RYR2	2.76e-05	3	106	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR1 RYR2	2.76e-05	3	106	2	11159936
Pubmed	Decreased expression of FGFR1, SOS1, RAF1 genes in cryptorchidism.	FGFR1 SOS1	2.76e-05	3	106	2	20389169
Pubmed	Intracellular calcium release channel expression during embryogenesis.	RYR1 RYR2	2.76e-05	3	106	2	9986730
Pubmed	Germline mutations of DICER1 in Chinese women with BRCA1/BRCA2-negative familial breast cancer.	DICER1 BRCA2	2.76e-05	3	106	2	25526195
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR1 RYR2	2.76e-05	3	106	2	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR1 RYR2	2.76e-05	3	106	2	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR1 RYR2	2.76e-05	3	106	2	7635066
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ING3 POLR2A MECOM KAT2A REV3L DICER1 BPTF FAT1 HMCN2 EHMT1 CSMD1 SEZ6L SOS1	3.59e-05	1116	106	13	31753913
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	MYF5 GNPTAB VSIG4 REV3L RRM1 DICER1 RYR1 HAVCR2 NLGN3 FAT1 LRP6 MTARC2 CSMD1 HYDIN	3.91e-05	1293	106	14	15342556
Pubmed	A Critical Role for Estrogen-Related Receptor Signaling in Cardiac Maturation.	DDR2 PEG3 RYR2 FGFR1	5.08e-05	66	106	4	32212902
Pubmed	Whole exome sequencing identifies mutations in 10% of patients with familial non-syndromic cleft lip and/or palate in genes mutated in well-known syndromes.	TP63 LRP6	5.50e-05	4	106	2	29500247
Pubmed	EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.	MECOM TP63	5.50e-05	4	106	2	23665236
Pubmed	Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release.	RYR1 RYR2	5.50e-05	4	106	2	23992453
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR1 RYR2	5.50e-05	4	106	2	23413940
Pubmed	Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy.	MYF5 RYR1	5.50e-05	4	106	2	30770808
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR1 RYR2	5.50e-05	4	106	2	9607712
Pubmed	Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.	BRCA2 TP63	5.50e-05	4	106	2	24880342
Pubmed	Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells.	FGFR1 SOS1	5.50e-05	4	106	2	7559490
Pubmed	Hypoxia differently modulates gene expression of inositol 1,4,5-trisphosphate receptors in mouse kidney and HEK 293 cell line.	RYR1 RYR2	5.50e-05	4	106	2	19120137
Pubmed	FKBP binding characteristics of cardiac microsomes from diverse vertebrates.	RYR1 RYR2	5.50e-05	4	106	2	11237759
Pubmed	Origin of the ultimobranchial body cyst: T/ebp/Nkx2.1 expression is required for development and fusion of the ultimobranchial body to the thyroid.	TG TP63	5.50e-05	4	106	2	16342117
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR1 RYR2	5.50e-05	4	106	2	23482488
Pubmed	Neuroligin 1, 2, and 3 Regulation at the Synapse: FMRP-Dependent Translation and Activity-Induced Proteolytic Cleavage.	NLGN3 NLGN2	5.50e-05	4	106	2	30056576
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR1 RYR2	5.50e-05	4	106	2	18206662
Pubmed	Increase of ryanodine receptors by dopamine D1 receptors is negatively regulated by γ-aminobutyric acid type B receptors in primary cultures of mouse cerebral cortical neurons.	RYR1 RYR2	5.50e-05	4	106	2	22504960
Pubmed	The p300 acetylase is critical for ligand-activated farnesoid X receptor (FXR) induction of SHP.	KAT2A NR1H4	5.50e-05	4	106	2	18842595
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN3 NLGN2	5.50e-05	4	106	2	12669065
Pubmed	The C-terminal Region and SUMOylation of Cockayne Syndrome Group B Protein Play Critical Roles in Transcription-coupled Nucleotide Excision Repair.	POLR2A UBE2I	5.50e-05	4	106	2	26620705
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN3 NLGN2	5.50e-05	4	106	2	22671294
Pubmed	PW1 gene/paternally expressed gene 3 (PW1/Peg3) identifies multiple adult stem and progenitor cell populations.	KRT15 PEG3	5.50e-05	4	106	2	21709251
Pubmed	Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade.	TP63 JAG1	5.50e-05	4	106	2	20038814
Pubmed	Cross-species comparison of 5-lipoxygenase-activating protein.	FGFR1 ALOX5AP	5.50e-05	4	106	2	1480129
Pubmed	A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.	BPTF TP63	5.50e-05	4	106	2	22797724
Pubmed	XPC is an RNA polymerase II cofactor recruiting ATAC to promoters by interacting with E2F1.	POLR2A KAT2A	5.50e-05	4	106	2	29973595
Pubmed	Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells.	FGFR1 SOS1	5.50e-05	4	106	2	7514169
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR1 RYR2	5.50e-05	4	106	2	9384575
Pubmed	S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor·Calmodulin Complex.	RYR1 RYR2	5.50e-05	4	106	2	27226555
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR1 RYR2	5.36e-05	3	77	2	287
GeneFamily	Adenosine receptors\|V-set domain containing	VSIG2 BTNL8 VSIG4 VSIR HAVCR2 CEACAM19	6.84e-05	163	77	6	590
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFHR1 CSMD3 CSMD1 SEZ6L	1.01e-04	57	77	4	1179
GeneFamily	X-linked mental retardation\|RNA helicases	HELQ DICER1	9.60e-04	11	77	2	1168
Coexpression	FOSTER_TOLERANT_MACROPHAGE_UP	TENT5C SLFN12L LOX JAG1 ZC3H12C DCBLD2 WNK2 SPIC	3.62e-07	166	105	8	M12595
Coexpression	FOSTER_TOLERANT_MACROPHAGE_UP	TENT5C SLFN12L LOX JAG1 ZC3H12C DCBLD2 WNK2 SPIC	8.93e-07	187	105	8	MM1034
Coexpression	ONDER_CDH1_TARGETS_1_DN	KRT15 KRT34 BRCA2 TP63 JAG1 UTP20 DCBLD2	5.69e-06	170	105	7	M6822
Coexpression	GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	UBE4B RYR1 NLGN3 ARHGEF10 ZC3H12C CTNND2 SEZ6L	1.59e-05	199	105	7	M312
Coexpression	GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP	GNPTAB HOXA7 SLFN12L UTP20 ZC3H12C LY75 SPIC	1.64e-05	200	105	7	M6558
Coexpression	KAUFFMANN_DNA_REPAIR_GENES	PARP3 REV3L RRM1 UBE2I BRCA2 TP63 DCLRE1A	4.01e-05	230	105	7	M11563
Coexpression	GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN	SI SPINK14 ST8SIA6 ZFYVE26 SDK1 SEZ6L	4.45e-05	159	105	6	M6086
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	KRT15 DDR2 TENT5C REV3L C2CD3 ST8SIA6 LOX TP63 JAG1 ADAMTS20 FGFR1 CTNND2 LY75 DCBLD2 EPHA7	3.93e-06	769	102	15	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 CSMD3 RYR2 FAT1 ADAMTS20 CSMD1 SDK1 HYDIN EPHA7	6.14e-10	184	106	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 CSMD3 RYR2 FAT1 ADAMTS20 CSMD1 SDK1 HYDIN EPHA7	6.14e-10	184	106	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 CSMD3 RYR2 FAT1 ADAMTS20 CSMD1 SDK1 HYDIN EPHA7	6.14e-10	184	106	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK3 CSMD3 NLGN3 LRP6 FGFR1 CSMD1 HYDIN SEZ6L	2.65e-08	199	106	8	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	MYF5 CSMD3 RYR2 CTNND2 CSMD1 SEZ6L	1.38e-06	146	106	6	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell\|E18.5-samps / Age Group, Lineage, Cell class and subclass	KRT15 TENT5C RRAGB SPATA21 CD96 WNK2	1.55e-06	149	106	6	82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f
ToppCell	E18.5-samps-Epithelial-Epithelial-non_alveolar\|E18.5-samps / Age Group, Lineage, Cell class and subclass	KRT15 TENT5C RRAGB SPATA21 CD96 WNK2	1.55e-06	149	106	6	14a01ae540db8a350ea26a350b2e6ce6c07639d9
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VSIG2 PARP3 TINAG HMCN2 VNN1 TP63	2.52e-06	162	106	6	34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DOCK3 MYF5 KPRP CSMD3 HYDIN WNK2	2.52e-06	162	106	6	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VSIG2 PARP3 TINAG HMCN2 VNN1 TP63	2.61e-06	163	106	6	56b8668dbf06faa6866ec71f29b92907b73f074d
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT15 NLGN3 MS4A1 ZFYVE26 MSS51 SDK1	3.00e-06	167	106	6	4520ee71e2b119c1dfa0e342fe57eda5f3598650
ToppCell	facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TENT5A RYR1 HAVCR2 ST8SIA6 CTNND2 ALOX5AP	3.32e-06	170	106	6	6686d1797988216c0d9417f21a2537369abce410
ToppCell	Nasal_Brush-Epithelial-Basal_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	KRT15 KAT2A RYR1 ST8SIA6 TP63 FGFR1	3.56e-06	172	106	6	58eaadf12366701103a0d1f133462c9495fedc30
ToppCell	Nasal_Brush-Epithelial-Basal_1\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	KRT15 KAT2A RYR1 ST8SIA6 TP63 FGFR1	3.56e-06	172	106	6	4483073469001770015526303772fd54906c5d68
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HGD FAT1 TINAG HYDIN NR1H4 EPHA7	5.08e-06	183	106	6	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RYR2 FAT1 JAG1 KCNMB1 CSMD1 SDK1	5.57e-06	186	106	6	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HAVCR2 FAT1 TINAG SDK1 NR1H4 EPHA7	5.75e-06	187	106	6	9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RYR2 FAT1 JAG1 KCNMB1 CSMD1 SDK1	6.30e-06	190	106	6	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TENT5A DDR2 TBC1D8B HMCN2 LOX FGFR1	7.09e-06	194	106	6	439d3f17c1f4736122b330e98add9292c7036a8e
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TENT5C MECOM FAT1 CTNND2 WNK2 EPHA7	7.30e-06	195	106	6	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	KRT15 VSIG2 MECOM TP63 SDK1 WNK2	7.52e-06	196	106	6	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK3 CSMD3 NLGN3 FGFR1 CSMD1 SEZ6L	8.20e-06	199	106	6	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK3 CSMD3 NLGN3 FGFR1 CSMD1 SEZ6L	8.20e-06	199	106	6	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	COVID-19-kidney-Epithelial_Doublet\|kidney / Disease (COVID-19 only), tissue and cell type	KRT34 CSMD3 RYR1 RYR2 MS4A1	1.19e-05	124	106	5	d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9
ToppCell	facs-Marrow-B-cells-24m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMPRSS15 KPRP CTNND2 CSMD1 ALOX5AP	2.37e-05	143	106	5	6df16bf0324661cd9707df69cb39f4b5498d6d49
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 KPRP CSMD3 HYDIN WNK2	2.53e-05	145	106	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TMPRSS15 SI CSMD3 RYR1 ADAMTS20	2.98e-05	150	106	5	0205318a870e091add66ee4305747dda9f51510d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNPTAB HAVCR2 SLFN12L ALOX5AP CD96	3.70e-05	157	106	5	170197b76620df31495f1247f365da382b2d8045
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNPTAB HAVCR2 SLFN12L ALOX5AP CD96	3.70e-05	157	106	5	c21520301cc0d5d4b1cc4b8ec735f9adb698e768
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	GNPTAB HAVCR2 SLFN12L ALOX5AP CD96	3.82e-05	158	106	5	7274f020c0ecf216da4b6689c62bc5f49c29b6f3
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD3 RYR1 RYR2 CTNND2 CSMD1	3.93e-05	159	106	5	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PEG3 NLGN3 KCNMB1 NLGN2 EPHA7	3.93e-05	159	106	5	7cda111bb98f1241989e49d490bdf51a712ea589
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TBC1D8B VNN1 MSS51 ALOX5AP CXCR1	4.05e-05	160	106	5	bb1bb3673059768c0ea0160d29fff127f3a4ecb4
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TBC1D8B VNN1 MSS51 ALOX5AP CXCR1	4.05e-05	160	106	5	76f49b8b4450fa8acd36326bfa36a5d1f4bd95fb
ToppCell	droplet-Heart-nan-24m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5C RYR1 CEACAM19 CTNND2 LY75	4.17e-05	161	106	5	7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab
ToppCell	Club_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CFHR1 TENT5C MECOM WNK2 EPHA7	4.17e-05	161	106	5	342f5c61d37df61b35c18f5d258043a8f5cef629
ToppCell	droplet-Fat-Gat-18m-Myeloid-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VSIG4 HAVCR2 CTNND2 ALOX5AP SPIC	4.30e-05	162	106	5	052f797d8bcab8fc6a43e0bffdd215c88ee12889
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD3 RYR1 RYR2 CTNND2 CD96	4.43e-05	163	106	5	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	droplet-Kidney-KIDNEY-30m-Myeloid-macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A VSIG4 VSIR HAVCR2 ALOX5AP	4.56e-05	164	106	5	e19fc6ba049336ab989a3a968bdbefd567971d73
ToppCell	droplet-Kidney-KIDNEY-30m-Myeloid\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A VSIG4 VSIR HAVCR2 ALOX5AP	4.56e-05	164	106	5	d6526551d0b183c3ef027ba3dbfddeac03fd93bb
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A RYR1 HAVCR2 CTNND2 ALOX5AP	4.69e-05	165	106	5	2477b0f1a0ea26184cf3cc4a9ffcdfa825cbc615
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TENT5C MFSD4B VSIR HAVCR2 ALOX5AP	4.83e-05	166	106	5	063d68f2ffb40770cb4601fa1cb6426ae26f7a37
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VSIG2 MECOM TINAG IGFALS BRCA2	4.83e-05	166	106	5	575c325db88d6909cdf0d5e664bd9098b89d4401
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TENT5C MFSD4B VSIR HAVCR2 ALOX5AP	4.83e-05	166	106	5	417cfb207da08fa1a0fd5f2a13c8786628667a8e
ToppCell	10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega\|bone_marrow / Manually curated celltypes from each tissue	HOXA7 HMCN2 ST8SIA6 LOX ZC3H12C	4.83e-05	166	106	5	a853005a5587d42daecdf2e23a93109919021a4f
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TENT5C MFSD4B VSIR HAVCR2 ALOX5AP	4.83e-05	166	106	5	f28d07715e6b00ca2a0df39273c5f569744be5a8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CSMD3 RYR1 CTNND2 CSMD1 SEZ6L	4.97e-05	167	106	5	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	VSIG4 MFSD4B TBC1D8B VSIR KCNMB1	4.97e-05	167	106	5	942134bbabe9972fae80cbc4ed4e94da52f55dc3
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FAT1 SDK1 HYDIN NR1H4 EPHA7	5.11e-05	168	106	5	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VSIG4 HORMAD1 VSIR VNN1 KCNMB1	5.26e-05	169	106	5	b2fdf9f842dc7c181bc951a8a6932c916ed835ef
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MTMR8 VSIG4 VSIR VNN1 ALOX5AP	5.26e-05	169	106	5	c100a91be9b94bd433a3b172f4a1bfb9d2393003
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VSIG4 HORMAD1 VSIR VNN1 KCNMB1	5.26e-05	169	106	5	2322f03a115c662f808ebfc892192b7d38d48181
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A RYR1 ST8SIA6 FGFR1 CTNND2	5.26e-05	169	106	5	735655e75511c5c41aca667909e8bb52a0ad7fc6
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	DOCK3 VSIG4 RYR2 TG CTNND2	5.41e-05	170	106	5	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENT5A HAVCR2 ST8SIA6 CTNND2 ALOX5AP	5.56e-05	171	106	5	7c4362eeacbe52d7f4fdf93c841d7b59526328c1
ToppCell	droplet-Thymus-nan-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAVCR2 CELSR3 CTNND2 ALOX5AP EPHA7	5.56e-05	171	106	5	25493a4a7b636920e2cfd984542cc500709c9dcf
ToppCell	droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAVCR2 CELSR3 CTNND2 ALOX5AP EPHA7	5.56e-05	171	106	5	508b41e3ad2638f9dd546d251b13ff60fc8c3207
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TENT5A RYR1 ST8SIA6 FGFR1 CTNND2	5.56e-05	171	106	5	38a05b5ec8ef8f09a2399994c6b4b9a707918ec1
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SI CSMD3 RYR1 CSMD1 CD96	5.56e-05	171	106	5	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	control-Myeloid-Mast_cell\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	HAVCR2 ST8SIA6 SPATA21 KCNMB1 ALOX5AP	5.71e-05	172	106	5	c1c99e6732234a6649a79610e99390db0c8f19b0
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KRT15 RYR1 C4orf17 FAT1 TP63	5.71e-05	172	106	5	e9095c3dac66cf93d31f5f88364b565abacb1e2d
ToppCell	facs-Marrow-T-cells-24m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYF5 RYR1 CTNND2 SDK1 WNK2	5.87e-05	173	106	5	ca3d2a9562734f76127e3e7d54c10b63e95141bb
ToppCell	facs-Marrow-T-cells-24m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYF5 RYR1 CTNND2 SDK1 WNK2	5.87e-05	173	106	5	19a9e10885173d7712996be8660a3a5a7a9aa39f
ToppCell	severe_influenza-Neutrophil\|severe_influenza / disease group, cell group and cell class (v2)	BTNL8 VNN1 LRP6 WNK2 CXCR1	5.87e-05	173	106	5	615e266419b9f06e964eff73cb466f05451ba0dd
ToppCell	droplet-Thymus-nan-3m-Myeloid-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAVCR2 CELSR3 CTNND2 ALOX5AP EPHA7	5.87e-05	173	106	5	63f03abca84ae021ff34ff34537838aa8a1ccd11
ToppCell	ASK428-Immune-B_cell\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	MRM3 UBE2I MS4A1 ARHGEF10 CSMD1	6.04e-05	174	106	5	b5a7a612a515736cf3489afd0f6ad2054d54526f
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RRAGB NLGN3 C2CD3 PITPNB CTNND2	6.20e-05	175	106	5	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	ASK428-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	MS4A1 ARHGEF10 LRP6 ZC3H12C CSMD1	6.20e-05	175	106	5	e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 RYR2 MS4A1 CSMD1 HYDIN	6.20e-05	175	106	5	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RYR1 HAVCR2 FGFR1 CTNND2 ALOX5AP	6.37e-05	176	106	5	7d1e2627d7ec5ddd6c87c55d2a6879255b76949e
ToppCell	facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TENT5A HAVCR2 ST8SIA6 CTNND2 ALOX5AP	6.37e-05	176	106	5	a85ad8b4815fde72edd5c900e882a0bc04033ea8
ToppCell	ASK428-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	KRT15 TG UBE2I TP63 EHMT1	6.55e-05	177	106	5	66074a288501c136b4e83b883db5f0d8269ee326
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HOXA7 ARHGEF10 FGFR1 CTNND2 ALOX5AP	6.90e-05	179	106	5	d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159
ToppCell	COVID-19-kidney-tDL\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HGD FAT1 TINAG NR1H4 EPHA7	7.09e-05	180	106	5	864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCell	facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RRAGB CEACAM19 FAT1 JAG1 KCNMB1	7.27e-05	181	106	5	429df38438d5a7ff490c9ede34b69e2970c7ded2
ToppCell	facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RRAGB CEACAM19 FAT1 JAG1 KCNMB1	7.27e-05	181	106	5	395cf5aa2d89b05328ab516b8c89401020b6d830
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	KRT15 MECOM FAT1 TP63 SDK1	7.47e-05	182	106	5	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	VSIG4 VSIR HAVCR2 KCNMB1 ALOX5AP	7.47e-05	182	106	5	c6b3762ccec326f057819f75fa7fac0145fb7d54
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KRT15 VSIG2 TP63 CD96 WNK2	7.47e-05	182	106	5	678eadd57e7e830fc2bf9fd35616d3badce01705
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KRT15 VSIG2 TP63 CD96 WNK2	7.47e-05	182	106	5	8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c13-HAVCR2\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MTMR8 HAVCR2 DCLRE1A FGFR1 CD96	7.47e-05	182	106	5	6c9a48037fa002bc528875538bdaaf15696d68b6
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 DDR2 PEG3 RYR2 EPHA7	7.66e-05	183	106	5	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PCDHGA6 MECOM ST8SIA6 ARHGEF10 LOX	7.66e-05	183	106	5	351d575339038bd4a66f408da518c567444208e8
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	PSMD2 TP63 JAG1 SDK1 WNK2	7.86e-05	184	106	5	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PEG3 CSMD3 IGFALS CTNND2 CXCR1	7.86e-05	184	106	5	7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 NLGN2 CTNND2 CSMD1 SEZ6L	7.86e-05	184	106	5	278a7ed764c326450cb70e69ed2175980eaf5fe0
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN3 NLGN2 CTNND2 CSMD1 SEZ6L	7.86e-05	184	106	5	8d86e125257ff1d3af8d90577a8b3f0321eca21c
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HAVCR2 SLFN12L ST8SIA6 ALOX5AP CD96	8.27e-05	186	106	5	885aed2472cead81d60c9f3a28c0ff10eb449592
ToppCell	(8)_CD34_progenitor\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MECOM HOXA7 MS4A1 LOX ZC3H12C	8.27e-05	186	106	5	943c604a7cd873faf510096d094100512ba2d6bc
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VSIG4 CSMD3 RYR2 ADAMTS20 CSMD1	8.27e-05	186	106	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 TINAG SDK1 HYDIN EPHA7	8.27e-05	186	106	5	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	(8)_CD34_progenitor\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	MECOM HOXA7 MS4A1 LOX ZC3H12C	8.27e-05	186	106	5	e69a986b8618effd61875fda528a2e44aab11868
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RYR2 FAT1 JAG1 KCNMB1 CSMD1	8.27e-05	186	106	5	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TINAG SDK1 HYDIN NR1H4 EPHA7	8.27e-05	186	106	5	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	Adult-Epithelial-club_cell-D231\|Adult / Lineage, Cell type, age group and donor	TENT5C MECOM FAT1 WNK2 EPHA7	8.48e-05	187	106	5	ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	VSIG4 HORMAD1 RYR1 VNN1 ALOX5AP	8.48e-05	187	106	5	23be50d81f4404a609dea821e1a66d221c0e0615
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SECISBP2L MECOM TINAG VNN1 EPHA7	8.48e-05	187	106	5	6ab51e17a7782c2ae6394cad813dc3a2cde70c89
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	VSIG4 VSIR HAVCR2 KCNMB1 ALOX5AP	8.48e-05	187	106	5	98026c1aaf8de280470ad75536121357934fc78d
ToppCell	COVID-19-kidney-tDL\|kidney / Disease (COVID-19 only), tissue and cell type	HAVCR2 FAT1 TINAG SDK1 NR1H4	8.48e-05	187	106	5	d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SECISBP2L MECOM TINAG VNN1 EPHA7	8.48e-05	187	106	5	e176b5b051690f840f3b12c8f7c4cc10cbe2bbae
Disease	non-small cell lung carcinoma	SECISBP2L BPTF BRCA2 TP63 NR1H4	6.68e-06	75	103	5	EFO_0003060
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR1 RYR2	3.61e-05	3	103	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR1 RYR2	3.61e-05	3	103	2	DOID:8545 (implicated_via_orthology)
Disease	Malignant Squamous Cell Neoplasm	BRCA2 TP63	3.61e-05	3	103	2	C0751688
Disease	Squamous Cell Neoplasms	BRCA2 TP63	3.61e-05	3	103	2	C0206720
Disease	post-operative stroke, response to surgery	RYR2 TP63	1.20e-04	5	103	2	EFO_0009951, EFO_0009956
Disease	osteoarthritis (is_implicated_in)	TENT5A DDR2 FGFR1	1.27e-04	28	103	3	DOID:8398 (is_implicated_in)
Disease	Giant Cell Glioblastoma	FAT1 JAG1 FGFR1 CTNND2	2.18e-04	84	103	4	C0334588
Disease	myeloid neoplasm (is_implicated_in)	MECOM FGFR1	2.51e-04	7	103	2	DOID:0070004 (is_implicated_in)
Disease	arteriosclerosis (implicated_via_orthology)	LOX MAP3K7	2.51e-04	7	103	2	DOID:2349 (implicated_via_orthology)
Disease	cathepsin S measurement	GNPTAB HORMAD1	3.33e-04	8	103	2	EFO_0008073
Disease	psoriasis	KPRP REV3L MFSD4B BPTF TP63 CSMD1	4.01e-04	273	103	6	EFO_0000676
Disease	corpus callosum volume measurement	TG JAG1 WNK2 SOS1	4.25e-04	100	103	4	EFO_0010299
Disease	Malignant neoplasm of salivary gland	KRT15 FAT1 JAG1	5.27e-04	45	103	3	C0220636
Disease	Salivary Gland Neoplasms	KRT15 FAT1 JAG1	5.99e-04	47	103	3	C0036095
Disease	peanut allergy measurement, parental genotype effect measurement	MRPL42 RYR1	6.50e-04	11	103	2	EFO_0005939, EFO_0007017
Disease	quality of life during menstruation measurement, acne	TENT5A SDK1	6.50e-04	11	103	2	EFO_0003894, EFO_0009366
Disease	Oligodontia	LRP6 FGFR1	7.78e-04	12	103	2	C4082304
Disease	Myeloproliferative disease	MECOM FGFR1	7.78e-04	12	103	2	C0027022
Disease	Adenocarcinoma of lung (disorder)	DDR2 RRM1 MS4A1 TP63 SOS1	7.95e-04	206	103	5	C0152013
Disease	Squamous cell carcinoma	DDR2 MS4A1 TP63 FGFR1	9.53e-04	124	103	4	C0007137
Disease	unipolar depression	DDR2 CSMD3 BPTF SLFN12L FAT1 MS4A1 ARHGEF10 CTNND2 CSMD1 LY75 SDK1 EPHA7	1.02e-03	1206	103	12	EFO_0003761
Disease	Psoriasis	VNN1 ZC3H12C CSMD1	1.05e-03	57	103	3	C0033860
Disease	Pustulosis of Palms and Soles	VNN1 ZC3H12C CSMD1	1.05e-03	57	103	3	C0030246
Disease	urokinase plasminogen activator surface receptor measurement	LY75 DCBLD2	1.07e-03	14	103	2	EFO_0010932
Disease	Hypodontia	LRP6 FGFR1	1.07e-03	14	103	2	C0020608
Disease	response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin	VSIG2 CSMD1	1.07e-03	14	103	2	EFO_0005400, GO_0036275, GO_1902518, GO_1902520
Disease	N-acetylmethionine measurement	DOCK3 EPHA7	1.23e-03	15	103	2	EFO_0021427
Disease	Malignant neoplasm of breast	MTMR8 MECOM HELQ PKDREJ BRCA2 SPATA21 JAG1 EHMT1 UTP20 ZFYVE26 FGFR1	1.33e-03	1074	103	11	C0006142
Disease	ascending aortic diameter	C3orf20 RYR2 KCNMB1 HYDIN	1.49e-03	140	103	4	EFO_0021787
Disease	acute lymphoblastic leukemia	CFHR1 RYR2 TP63	1.61e-03	66	103	3	EFO_0000220
Disease	schizophrenia (implicated_via_orthology)	CSMD3 NLGN2 CSMD1	1.76e-03	68	103	3	DOID:5419 (implicated_via_orthology)
Disease	joint damage measurement	MECOM TG CSMD1	1.76e-03	68	103	3	EFO_0005413
Disease	cortical thickness change measurement	CSMD1 EPHA7	1.78e-03	18	103	2	EFO_0021501
Disease	adenosine monophosphate measurement	RRM1 CSMD3	1.78e-03	18	103	2	EFO_0010454
Disease	autism spectrum disorder (implicated_via_orthology)	NLGN3 ARHGEF10 NLGN2 CTNND2	2.02e-03	152	103	4	DOID:0060041 (implicated_via_orthology)
Disease	exercise test	RYR2 ZC3H12C	2.20e-03	20	103	2	EFO_0004328
Disease	glomerulonephritis (biomarker_via_orthology)	MS4A1 ALOX5AP	2.20e-03	20	103	2	DOID:2921 (biomarker_via_orthology)
Disease	citrulline measurement	MECOM HMCN2	2.20e-03	20	103	2	EFO_0009777
Disease	Lung Neoplasms	SECISBP2L BRCA2 TP63 JAG1 FGFR1	2.41e-03	265	103	5	C0024121
Disease	Malignant neoplasm of lung	SECISBP2L BRCA2 TP63 JAG1 FGFR1	2.45e-03	266	103	5	C0242379
Disease	otitis media (implicated_via_orthology)	MECOM FGFR1	2.66e-03	22	103	2	DOID:10754 (implicated_via_orthology)
Disease	Glioblastoma	FAT1 JAG1 CTNND2	2.69e-03	79	103	3	C0017636
Disease	brain connectivity measurement	ADAMTS20 MAP3K7 WNK2 TANGO6 EPHA7 SOS1	2.83e-03	400	103	6	EFO_0005210
Disease	Carcinoma of lung	BRCA2 TP63	2.91e-03	23	103	2	C0684249
Disease	QRS duration, response to sulfonylurea	TINAG CSMD1	2.91e-03	23	103	2	EFO_0005055, EFO_0007922
Disease	brain measurement, neuroimaging measurement	TG BPTF JAG1 ADAMTS20 MAP3K7 WNK2 TANGO6	3.20e-03	550	103	7	EFO_0004346, EFO_0004464
Disease	myeloproliferative disorder	MECOM PSMD2	3.44e-03	25	103	2	EFO_0004251
Disease	Dwarfism	TG IGFALS	3.44e-03	25	103	2	C0013336
Disease	Cancer of Neck	FAT1 TP63	3.44e-03	25	103	2	C0746787
Disease	neutrophil measurement	TENT5A TENT5C PSMD2 GFM1	3.49e-03	177	103	4	EFO_0803548

Protein segments in the cluster

Peptide	Gene	Start	Entry
ERVYTANQNCVDAYP	ALOX5AP	51	P20292
IECAAYNPEPYLNNE	ARHGEF10	896	O15013
VITSPNYPVQYEDNA	CSMD1	421	Q96PZ7
YQAYQLQSCPDPRPF	CSMD3	2216	Q7Z407
YPSYNEQNGTPIVIC	BTNL8	446	Q6UX41
YTYNNITCASPPEVV	IGFALS	576	P35858
NLYSYENQPQPSDEC	DICER1	1221	Q9UPY3
YINIYNCEPANPSEK	MS4A1	161	P11836
YNPSDSPFYQCAEVL	BPTF	3006	Q12830
DPYRQLQYCPSVESP	CTNND2	501	Q9UQB3
NYHQPIDENYCDPEV	ADAMTS20	1236	P59510
YQPICGTNFITYDNP	SPINK14	61	Q6IE38
IANCREYNPPDSEYC	KAT2A	801	Q92830
PCSYLEELEPQDYQQ	NOBOX	496	O60393
LEVEPYSQYSNVQFP	NR1H4	51	Q96RI1
SNPGTQVYEDYNCTL	PARP3	56	Q9Y6F1
QQCSYIPGSVDNYQT	KCNMB1	101	Q16558
ATNNECVYGNYPEIP	MECOM	11	Q03112
DVNDNAPQTSEPVYY	FAT1	1131	Q14517
IICVYFQPPFQNSQY	OR1B1	261	Q8NGR6
PQPNYADTLINQESY	PCDHGA6	771	Q9Y5G7
TYNENNLVDGVYCLP	EPM2A	111	O95278
QVENYYSLPGQSCSE	MYF5	141	P13349
TQLNNIPPTQESYYD	GNPTAB	1066	Q3T906
QVYSSPNKQPVYCSA	MSS51	421	Q4VC12
ANRNYEICSTYPPEI	MTMR8	151	Q96EF0
QTYLPQPAICPDSVY	DDR2	811	Q16832
VENNPAYLYCDTNAI	HMCN2	2771	Q8NDA2
VNYTDYIQPICLPEE	TMPRSS15	886	P98073
DPNEPRYCICNQVSY	ING3	356	Q9NXR8
EPLQYPCQYSDEGQS	MAP3K7	296	O43318
QYLSAEENYESCPPS	LRP6	1576	O75581
EPNVPYNKTPNCVSY	LY75	451	O60449
YQKQTPTSPECDYSQ	KRT15	141	P19012
LDENYTPIRTYQVCQ	EPHA7	61	Q15375
APTDPQTSYAQEQYA	PEG3	1011	Q9GZU2
YLECCQVSNSDPPRY	MAGEA13P	251	A6NCF6
TEPTAEVYNQYPSNA	MFSD4B	476	Q5TF39
LPCSVQEYQVGQLYS	PITPNB	11	P48739
EPNEDCLYLNVYVPT	NLGN3	136	Q9NZ94
LQYCPDPYIQRFVET	TP63	11	Q9H3D4
IFQNYTPCEVYEVPL	HYDIN	106	Q4G0P3
VYCISELNDPQYDQS	C2CD3	431	Q4AC94
LQCDAQYLQIYAVTP	DOCK3	1411	Q8IZD9
PATCYTNQSPYSVIE	BRCA2	1651	P51587
LEYCYNPSHNPEEQL	FGFR1	581	P11362
VYYPSGNVAVCQIPT	C3orf20	386	Q8ND61
IQEYNLCPQRACYPS	C4orf17	341	Q53FE4
ESTYGTPQTCYPNNE	CENPJ	816	Q9HC77
QAYHPNNSSPVCYEV	CXCR1	176	P25024
YQQDLLNPDPAPYCQ	CEACAM19	281	Q7Z692
PTLDQNFQVAYPDYC	MTARC2	196	Q969Z3
NPSYLVPESDYTNNV	LOX	381	P28300
NQVIYLNPPIEECRY	DYNC1H1	966	Q14204
TETCYVECPVQNYVP	KPRP	141	Q5T749
SINYPQTYPNSTVCE	DCBLD2	86	Q96PD2
YCSPEYTFPSQQEVI	DCLRE1A	841	Q6PJP8
VYTNPEDPQTISECY	HORMAD1	101	Q86X24
YLTTPYDLVSQCNPD	HELQ	871	Q8TDG4
VYAPASSVEYQCQNL	CFHR1	226	Q03591
PQYNYQTLVPENEAA	CELSR3	326	Q9NYQ7
EYSRYQPCLPSTQED	GFM1	716	Q96RP9
EYQQRNITSPEVNYC	SDK1	816	Q7Z5N4
LEPQLNEYNACSVYT	RYR1	3206	P21817
ISNECYQYSPEFPLD	RYR2	1771	Q92736
VNAVDSEPCPSNYKY	EHMT1	1026	Q9H9B1
SEPCPSNYKYVSQNC	EHMT1	1031	Q9H9B1
NQSEDCLYLNLYVPT	NLGN2	136	Q8NFZ4
AYGNLPCASYDQNIP	HOXA7	76	P31268
NPQVCPYNLYAEQLS	HGD	31	Q93099
YSIYIACEPSPSANN	JAG1	996	P78504
NNEYYPADLQVAPTQ	UTP20	851	O75691
PLNNFLECTYNVTVY	SEZ6L	301	Q9BYH1
YAPNLQSPYAQVPCI	SPATA21	391	Q7Z572
INLQPQDYNGLCDPY	FER1L5	1496	A0AVI2
QQEPLLCPSYQSYFK	KRT34	136	O76011
DPCQPYRSAFYVLEQ	NBPF12	1166	Q5TAG4
NYLPPDTRVYVADNC	MRM3	276	Q9HC36
LYLTSCVNYVPEPEN	PSMD2	231	Q13200
LPDNDPYDNLCYLVT	PKDREJ	1221	Q9NTG1
EPNEYYCYVSSRQQP	HAVCR2	276	Q8TDQ0
QPFVDYPYNQCAVVG	ST8SIA6	176	P61647
PSYLITCYPFVQENQ	SECISBP2L	51	Q93073
TTNQCRNDELNYPPY	SI	1406	P14410
IFYSQCVQPDQEYLS	SPIC	211	Q8N5J4
EITGEIQQYQNQPYC	SOS1	966	Q07889
IIPSATNVTCYYQPA	TENT5C	346	Q5VWP2
QDPAQAEAYTIYCQN	UBE2I	126	P63279
QCPPDGRYQYNTDVV	VNN1	151	O95497
YTCIQEPNESDLPYH	CD96	566	P40200
ETIYQEPFCSNPSDV	REV3L	1901	O60673
SCQYDLNSQVIYPES	SLFN12L	526	Q6IEE8
HDPSLPYLEQYQIDC	TBC1D8B	826	Q0IIM8
IDINYYPVPEACLSN	RRM1	481	P23921
YSPLPDDYNCNVELA	MRPL42	36	Q9Y6G3
YYDPNPQSTVVAEDQ	POLR2A	1176	P24928
VQYSPQALYEPCTQD	UBE4B	896	O95155
ATPYSLYVCPEGQNV	VSIR	36	Q9H7M9
PQQSLSPENYYRDIC	TANGO6	361	Q9C0B7
SPENYYRDICPQVLD	TANGO6	366	Q9C0B7
YYQSCLEAILQNSPD	RRAGB	166	Q5VZM2
NYSDEPCIGQEYQII	VSIG4	356	Q9Y279
PTQTYVKYQVPCQTQ	XP32	51	Q5T750
QTYSLPDNSTQPCYE	ZC3H12C	791	Q9C0D7
TSEYPYSECQNAAQI	WNK2	391	Q9Y3S1
NVEKSNRIYQCSPPY	TINAG	341	Q9UJW2
TGTYLCQVNNPPDFY	VSIG2	116	Q96IQ7
DQNVIPNVANVTCYY	TENT5A	391	Q96IP4
YLPQCQDSGDYAPVQ	TG	116	P01266
QCYSYCNKDVPEEPS	ZFYVE26	1866	Q68DK2